美国微生物学和细菌培养基市场规模、份额、趋势分析报告：按产品、应用、细分市场预测，2025-2030 年

美国微生物学和细菌培养基市场的成长和趋势

根据Grand View Research, Inc.的最新报告，美国微生物学和细菌培养基市场规模预计到2030年将达到29.5亿美元，2025年至2030年期间的复合年增长率为7.47%。

这种增长归因于对快速诊断的需求不断增加、感染疾病率不断上升、製药和食品检测应用不断扩大以及临床和工业领域微生物培养技术的不断进步。

抗生素抗药性 (AMR) 威胁日益加剧，显着增加了对微生物培养基的依赖，使其无法准确鑑定抗药性病原体。随着病原体对传统抗生素的抗药性不断增强，准确的微生物检测对于指导有效的治疗策略至关重要。这种日益增长的认知促使人们加强了对抗抗生素抗药性的研发，从而刺激了对先进细菌培养基的需求。因此，微生物培养仍然是药物开发、感染控制和临床诊断的重要工具，并推动了全部区域的市场成长。

此外，包括自动化系统和复杂鑑定方法在内的培养技术的持续进步，正在彻底改变微生物实验室。这些创新简化了工作流程，减少了人为错误，并显着提高了微生物检测的准确性和速度。样本处理和数据分析效率的提高使实验室能够满足对快速可靠结果日益增长的需求。此外，这些改进也支持製药、临床和研究环境中的法规遵循和品质保证。这些进步正在推动培养基的普及，刺激微生物市场的持续成长和竞争。

然而，先进设备和培养基的高昂成本限制了其应用，尤其是在小型实验室和新兴市场。此外，有些自动化系统较为复杂，需要专门的培训，这可能会成为实施的障碍。此外，污染风险和对精确环境控制的需求仍然存在，这可能会影响检测的可靠性和整体业务效率。

美国微生物学和细菌培养基市场报告重点

• 脱水培养基因其保质期长、易于储存，在2024年占据了最大的收入份额。此外，由于其成本效益高、易于製备，脱水培养基也受到许多实验室的青睐。预计在预测期内，即用型培养基细分市场将以最快的复合年增长率成长。
• 预计到2024年，製药和生物製药製造领域将占据应用领域的主导地位，收益占有率最高，达到38.13%，并有望在预测期内以最快的复合年增长率增长。这得益于疫苗和生技药品需求的不断增长。严格的品质和安全检测监管要求进一步推动了这一成长。然而，诊断领域预计将在预测期内实现显着成长。
• 2024年10月，美国药典委员会（USP）宣布收购总部位于明尼苏达州圣保罗的微生物技术公司Stratix Labs。这项策略性措施标誌着USP产品组合向前迈出的重要一步，增强了其微生物解决方案，支持包括生技药品和组合药物在内的各种製药应用中的微生物污染控制。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

• 市场展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国微生物学和细菌培养基市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析
  • COVID-19影响分析

第四章美国微生物学和细菌培养基市场：产品评估和趋势分析

• 细分仪表板
• 美国微生物学和细菌培养基市场的产品差异分析
• 2018-2030年美国微生物学及细菌培养基市场规模及产品趋势分析
• 干培养基
• 即用型培养基

第五章美国微生物学和细菌培养基市场：应用评估和趋势分析

• 细分仪表板
• 美国微生物及细菌培养基市场应用趋势分析
• 美国微生物学及细菌培养基市场规模及应用趋势分析（2018-2030）
• 食品和水检测
  • 食物
  • 动物饲料
  • 水质检测
• 诊断
• 製药和生物製药製造
• 生质能源与农业研究
• 化妆品和个人护理应用
• 其他的

第六章 竞争态势

• 公司分类
• 战略地图
• 公司简介/上市公司
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • bioMerieux SA
  • HiMedia Laboratories
  • BD
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • SHIMADZU
  • Hardy Diagnostics
  • Alpha Teknova, Inc.
  • MP Biomedicals

U.S. Microbiology And Bacterial Culture Media Market Growth and Trends:

The U.S. microbiology and bacterial culture media market size is anticipated to reach USD 2.95 billion by 2030 and is anticipated to grow at a CAGR of 7.47% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to increasing demand for rapid diagnostics, rising prevalence of infectious diseases, expanding pharmaceutical and food testing applications, and continuous advancements in microbial culture technologies across clinical and industrial sectors.

The rising threat of antimicrobial resistance (AMR) has significantly increased the reliance on microbiology culture media for accurate identification of drug-resistant pathogens. As pathogens evolve resistance to conventional antibiotics, precise microbial detection becomes critical to guide effective treatment strategies. This growing awareness has spurred intensified research and development efforts aimed at combating AMR, fueling demand for advanced bacterial culture media. Consequently, microbiology culture remains a vital tool in pharmaceutical development, infection control, and clinical diagnostics, thus propelling the market growth across the region.

In addition, Continuous technological advancements in culture techniques, including automated systems and sophisticated identification methods, have revolutionized microbiology laboratories. These innovations streamline workflows, reduce manual errors, and significantly improve the accuracy and speed of microbial detection. Enhanced efficiency in sample processing and data analysis enables laboratories to meet growing demands for rapid and reliable results. Furthermore, these improvements support regulatory compliance and quality assurance in pharmaceutical, clinical, and research settings. Collectively, such advancements drive increased adoption of culture media, thereby stimulating sustained growth and competitiveness in the microbiology market.

However, the high costs associated with advanced equipment and culture media limit adoption, especially among smaller laboratories and in emerging markets. Additionally, the complexity of some automated systems requires specialized training, which can be a barrier to implementation. Furthermore, contamination risks and the need for precise environmental controls remain persistent, potentially impacting test reliability and overall operational efficiency.

U.S. Microbiology And Bacterial Culture Media Market Report Highlights:

• The dehydrated culture media held the largest revenue share in 2024, owing to its long shelf life and ease of storage. Additionally, its cost-effectiveness and convenience in preparation make it the preferred choice for many laboratories. The ready-to-use media segment is expected to grow at the fastest CAGR over the forecast period.
• The pharmaceutical & biopharmaceutical production segment dominated the application segment with the largest revenue share of 38.13% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increased demand for vaccines and biologics. Stringent regulatory requirements for quality and safety testing further propel its growth. However,diagnostics are expected to grow significantly over the forecast period.
• In October 2024, the U.S. Pharmacopeia (USP) announced its acquisition of Stratix Labs, a microbiology technology company headquartered in Saint Paul, MN. This strategic move represents a significant advancement for USP's portfolio, enhancing its microbiological solutions to support microbial contamination control across various pharmaceutical applications, including biologics and compounded medications.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth in global food microbiology testing
    • 3.2.1.2. Rising need for high-quality culture media for diagnostic applications
    • 3.2.1.3. Continuous advancements in biopharmaceutical manufacturing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced or specialty media
    • 3.2.2.2. Growing preference for alternative methods like molecular diagnostics
• 3.3. U.S. Microbiology & Bacterial Culture Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Microbiology & Bacterial Culture Media Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. U.S. Microbiology & Bacterial Culture Media Market Product Movement Analysis
• 4.3. U.S. Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Dehydrated Culture Media
  • 4.4.1. Dehydrated Culture Media Market, 2018 - 2030 (USD Million)
• 4.5. Ready-to-use Media
  • 4.5.1. Ready-to-use Media Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Microbiology & Bacterial Culture Meida Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. U.S. Microbiology & Bacterial Culture Media Market Application Movement Analysis
• 5.3. U.S. Microbiology & Bacterial Culture Media Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Food & Water Testing
  • 5.4.1. Food & Water Testing Market, 2018 - 2030 (USD Million)
  • 5.4.2. Food
    • 5.4.2.1. Food Market, 2018 - 2030 (USD Million)
  • 5.4.3. Animal Feed
    • 5.4.3.1. Animal Feed Market, 2018 - 2030 (USD Million)
  • 5.4.4. Water Testing
    • 5.4.4.1. Water Testing Market, 2018 - 2030 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics Market, 2018 - 2030 (USD Million)
• 5.6. Pharmaceutical & Biopharmaceutical Production
  • 5.6.1. Pharmaceutical & Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
• 5.7. Bioenergy & Agricultural Research
  • 5.7.1. Bioenergy & Agricultural Research Market, 2018 - 2030 (USD Million)
• 5.8. Cosmetics and Personal Care Applications
  • 5.8.1. Cosmetics and Personal Care Applications Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategy Mapping
• 6.3. Company Profiles/Listing
  • 6.3.1. Thermo Fisher Scientific, Inc.
    • 6.3.1.1. Overview
    • 6.3.1.2. Financial Performance
    • 6.3.1.3. Product Benchmarking
    • 6.3.1.4. Strategic Initiatives
  • 6.3.2. Merck KGaA
    • 6.3.2.1. Overview
    • 6.3.2.2. Financial Performance
    • 6.3.2.3. Product Benchmarking
    • 6.3.2.4. Strategic Initiatives
  • 6.3.3. bioMerieux SA
    • 6.3.3.1. Overview
    • 6.3.3.2. Financial Performance
    • 6.3.3.3. Product Benchmarking
    • 6.3.3.4. Strategic Initiatives
  • 6.3.4. HiMedia Laboratories
    • 6.3.4.1. Overview
    • 6.3.4.2. Financial Performance
    • 6.3.4.3. Product Benchmarking
    • 6.3.4.4. Strategic Initiatives
  • 6.3.5. BD
    • 6.3.5.1. Overview
    • 6.3.5.2. Financial Performance
    • 6.3.5.3. Product Benchmarking
    • 6.3.5.4. Strategic Initiatives
  • 6.3.6. Neogen Corporation
    • 6.3.6.1. Overview
    • 6.3.6.2. Financial Performance
    • 6.3.6.3. Product Benchmarking
    • 6.3.6.4. Strategic Initiatives
  • 6.3.7. Bio-Rad Laboratories, Inc.
    • 6.3.7.1. Overview
    • 6.3.7.2. Financial Performance
    • 6.3.7.3. Product Benchmarking
    • 6.3.7.4. Strategic Initiatives
  • 6.3.8. SHIMADZU
    • 6.3.8.1. Overview
    • 6.3.8.2. Financial Performance
    • 6.3.8.3. Product Benchmarking
    • 6.3.8.4. Strategic Initiatives
  • 6.3.9. Hardy Diagnostics
    • 6.3.9.1. Overview
    • 6.3.9.2. Financial Performance
    • 6.3.9.3. Product Benchmarking
    • 6.3.9.4. Strategic Initiatives
  • 6.3.10. Alpha Teknova, Inc.
    • 6.3.10.1. Overview
    • 6.3.10.2. Financial Performance
    • 6.3.10.3. Product Benchmarking
    • 6.3.10.4. Strategic Initiatives
  • 6.3.11. MP Biomedicals
    • 6.3.11.1. Overview
    • 6.3.11.2. Financial Performance
    • 6.3.11.3. Product Benchmarking
    • 6.3.11.4. Strategic Initiatives

List of Tables

• Table 1 U.S. microbiology & bacterial culture media market estimates & forecasts
• Table 2 U.S. microbiology & bacterial culture media market estimates & forecasts, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. microbiology & bacterial culture media market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 U.S. microbiology & bacterial culture media market: Product outlook key takeaways
• Fig. 15 U.S. microbiology & bacterial culture media market: Product movement analysis
• Fig. 16 Dehydrated culture media market, 2018 - 2030 (USD Million)
• Fig. 17 Ready-to-use media market, 2018 - 2030 (USD Million)
• Fig. 18 U.S. microbiology & bacterial culture media market: Application outlook key takeaways
• Fig. 19 U.S. microbiology & bacterial culture media market: Application movement analysis
• Fig. 20 Food & water testing market, 2018 - 2030 (USD Million)
• Fig. 21 Food market, 2018 - 2030 (USD Million)
• Fig. 22 Animal feed market, 2018 - 2030 (USD Million)
• Fig. 23 Water testing market, 2018 - 2030 (USD Million)
• Fig. 24 Diagnostics market, 2018 - 2030 (USD Million)
• Fig. 25 Pharmaceutical & biopharmaceutical production market, 2018 - 2030 (USD Million)
• Fig. 26 Bioenergy & agricultural research market, 2018 - 2030 (USD Million)
• Fig. 27 Cosmetics and Personal Care Applications market, 2018 - 2030 (USD Million)
• Fig. 28 Others market, 2018 - 2030 (USD Million)
• Fig. 29 U.S. microbiology & bacterial culture media market, 2018 - 2030 (USD Million)
• Fig. 30 Key companies profiled